Mathew, P., Thall, P. F., Wen, S., Bucana, C., Jones, D., Horne, E., . . . Fidler, I. J. (2008). Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer. Nature Publishing Group.
Citación estilo ChicagoMathew, P., et al. Dynamic Change in Phosphorylated Platelet-derived Growth Factor Receptor in Peripheral Blood Leukocytes Following Docetaxel Therapy Predicts Progression-free and Overall Survival in Prostate Cancer. Nature Publishing Group, 2008.
Cita MLAMathew, P., et al. Dynamic Change in Phosphorylated Platelet-derived Growth Factor Receptor in Peripheral Blood Leukocytes Following Docetaxel Therapy Predicts Progression-free and Overall Survival in Prostate Cancer. Nature Publishing Group, 2008.